Published in J Urol on July 01, 1977
Adherence of Escherichia coli to human urinary tract epithelial cells. Infect Immun (1979) 2.39
Non-surgical management of recurrent urinary tract infections in women. Transl Androl Urol (2017) 0.75
Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med (1987) 6.41
Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Infectious Diseases Society of America (IDSA). Clin Infect Dis (1999) 5.99
Bacteriologic localization patterns in bacterial prostatitis and urethritis. Invest Urol (1968) 5.98
Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol (1989) 3.78
Antibacterial nature of prostatic fluid. Nature (1968) 3.68
Recurrent urinary infections in adult women. The role of introital enterobacteria. Calif Med (1971) 3.32
Zonal distribution of prostatic adenocarcinoma. Correlation with histologic pattern and direction of spread. Am J Surg Pathol (1988) 3.20
Studies of introital colonization in women with recurrent urinary infections. VII. The role of bacterial adherence. J Urol (1977) 3.20
Role of type 1 pili and effects of phase variation on lower urinary tract infections produced by Escherichia coli. Infect Immun (1985) 2.82
Classification of benign diseases associated with prostatic pain: prostatitis or prostatodynia? J Urol (1978) 2.74
Regulation of production of type 1 pili among urinary tract isolates of Escherichia coli. Infect Immun (1986) 2.65
Adherence of Escherichia coli to human urinary tract epithelial cells. Infect Immun (1979) 2.39
Resistance to nalidixic acid. A misconception due to underdosage. JAMA (1976) 2.31
Diffusion of antibiotics from plasma into prostatic fluid. Nature (1968) 2.18
Endoscopic suspension of the vesical neck for urinary incontinence. Surg Gynecol Obstet (1973) 2.06
Ultrasound guided transrectal core biopsies of the palpably abnormal prostate. J Urol (1989) 2.06
Serum versus urinary antimicrobial concentrations in cure of urinary-tract infections. N Engl J Med (1974) 2.05
Evaluation of the cytokines interleukin 8 and epithelial neutrophil activating peptide 78 as indicators of inflammation in prostatic secretions. Urology (2000) 1.92
Antiproliferative effects of 1,25-dihydroxyvitamin D3 on primary cultures of human prostatic cells. Cancer Res (1994) 1.85
Long-term results of the Stamey bladder neck suspension: direct comparison with the Marshall-Marchetti-Krantz procedure. J Urol (1998) 1.82
Patterns of progression in prostate cancer. Lancet (1986) 1.78
The role of vaginal colonization with enterobacteriaceae in recurrent urinary infections. J Urol (1975) 1.77
The histology of interstitial cystitis. Am J Surg Pathol (1990) 1.75
The periurethral glands do not significantly influence the serum prostate specific antigen concentration. J Urol (1996) 1.73
Chronic bacterial prostatitis and the diffusion of drugs into prostatic fluid. J Urol (1970) 1.69
Determination of prostate volume by transrectal ultrasound. J Urol (1991) 1.69
Relationship of type 1 pilus expression in Escherichia coli to ascending urinary tract infections in mice. Infect Immun (1987) 1.68
Uropathogenic Escherichia coli potentiates type 1 pilus-induced apoptosis by suppressing NF-kappaB. Infect Immun (2001) 1.66
Prostatitis. J R Soc Med (1981) 1.64
Treatment of urinary tract infection: what's old, what's new, and what works. World J Urol (1999) 1.62
Comparison of mid-lobe versus lateral systematic sextant biopsies in the detection of prostate cancer. Urol Int (1997) 1.60
The pathological features and prognosis of prostate cancer detectable with current diagnostic tests. J Urol (1994) 1.53
Endoscopic suspension of the vesical neck for urinary incontinence in females. Report on 203 consecutive patients. Ann Surg (1980) 1.45
Prophylactic efficacy of nitrofurantoin macrocrystals and trimethoprim-sulfamethoxazole in urinary infections. Biologic effects on the vaginal and rectal flora. N Engl J Med (1977) 1.44
The diffusion and concentration of trimethoprim in human vaginal fluid. J Infect Dis (1975) 1.44
Association of the Lewis blood-group phenotype with recurrent urinary tract infections in women. N Engl J Med (1989) 1.42
Assessment of morphometric measurements of prostate carcinoma volume. Cancer (2000) 1.42
The role of perineural space invasion in the local spread of prostatic adenocarcinoma. J Urol (1989) 1.40
The central role of prostate specific antigen in diagnosis and progression of prostate cancer. J Urol (1995) 1.40
Interstitial cystitis: early diagnosis, pathology, and treatment. Urology (1978) 1.40
Histologic differentiation, cancer volume, and pelvic lymph node metastasis in adenocarcinoma of the prostate. Cancer (1990) 1.40
Angiosarcoma of the bladder: a review. Urology (1998) 1.39
Comparison of prostate size in university and Veterans Affairs Health Care System patients with negative prostate biopsies. Urology (1998) 1.39
Effect of flutamide and flutamide plus castration on prostate size in patients with previously untreated prostate cancer. Urology (1996) 1.38
Diffusion of sulfonamides from plasma into prostatic fluid. J Urol (1970) 1.38
Multiple cancers in the prostate. Morphologic features of clinically recognized versus incidental tumors. Cancer (1992) 1.34
Keratin immunoreactivity in the benign and neoplastic human prostate. Cancer Res (1985) 1.32
Nerve sparing radical prostatectomy: a different view. J Urol (1995) 1.32
IL-1beta and TNF-alpha in prostatic secretions are indicators in the evaluation of men with chronic prostatitis. J Urol (2000) 1.31
Evaluation of the bacterial flora of the prostate using a 16S rRNA gene based polymerase chain reaction. J Urol (2000) 1.29
The immunologic basis of recurrent bacteriuria: role of cervicovaginal antibody in enterobacterial colonization of the introital mucosa. Medicine (Baltimore) (1978) 1.29
Association of vitro Escherichia coli adherence to vaginal and buccal epithelial cells with susceptibility of women to recurrent urinary-tract infections. N Engl J Med (1981) 1.29
Elevated levels of insulin-like growth factor-binding protein-2 in the serum of prostate cancer patients. J Clin Endocrinol Metab (1993) 1.26
Effect of carbohydrates on adherence of Escherichica coli to human urinary tract epithelial cells. Infect Immun (1980) 1.25
In vivo expression and variation of Escherichia coli type 1 and P pili in the urine of adults with acute urinary tract infections. Infect Immun (1989) 1.24
Prevalence and significance of prostatic inflammation. J Urol (1981) 1.23
Mannose-sensitive haemagglutination in the absence of piliation in Escherichia coli. Mol Microbiol (1990) 1.21
Clinical and roentgenographic evaluation of endoscopic suspension of the vesical neck for urinary incontinence. Surg Gynecol Obstet (1975) 1.19
An analysis of 148 consecutive transition zone cancers: clinical and histological characteristics. J Urol (2000) 1.16
Limitations of serum prostate specific antigen in predicting peripheral and transition zone cancer volumes as measured by correlation coefficients. J Urol (1996) 1.13
Preoperative serum prostate specific antigen does not reflect biochemical failure rates after radical prostatectomy in men with large volume cancers. J Urol (2000) 1.13
Bacteriologic and hormonal observations of the urethra and vaginal vestibule in normal, premenopausal women. J Urol (1970) 1.12
Observations on the clinical use of nalidixic acid. Postgrad Med J (1971) 1.12
Long-term results of radical retropubic prostatectomy in men with high grade carcinoma of the prostate. J Urol (1997) 1.11
Molecular mass and carbohydrate structure of prostate specific antigen: studies for establishment of an international PSA standard. Prostate (1995) 1.11
Physiological variation of serum prostate specific antigen in the 4.0 to 10.0 ng./ml. range in male volunteers. J Urol (1996) 1.11
Biofeedback, pelvic floor re-education, and bladder training for male chronic pelvic pain syndrome. Urology (2000) 1.11
Unsuspected adenocarcinoma of the prostate in patients undergoing cystoprostatectomy for other causes: incidence, histology and morphometric observations. J Urol (1989) 1.10
The role of excretory urography and cystoscopy in the evaluation and management of women with recurrent urinary tract infection. J Urol (1980) 1.07
The male bulbourethral sling procedure for post-radical prostatectomy incontinence. J Urol (1998) 1.06
Pathogenesis and biological significance of seminal vesicle invasion in prostatic adenocarcinoma. J Urol (1990) 1.04
The role of introital enterobacteria in recurrent urinary infections. J Urol (1973) 1.04
Recurrent urinary tract infections in female patients: an overview of management and treatment. Rev Infect Dis (1987) 1.04
Transitional cell carcinoma exhibiting clear cell features. A differential diagnosis for clear cell adenocarcinoma of the urinary tract. Arch Pathol Lab Med (1995) 1.03
Invasion of Denonvilliers' fascia in radical prostatectomy specimens. J Urol (1993) 1.03
Catheter-associated bacteriuria. Urol Clin North Am (1986) 1.02
The Riker method for determining formaldehyde in the presence of methenamine. Invest Urol (1971) 1.02
Studies of introital colonization in women with recurrent urinary infections. I. The role of vaginal pH. J Urol (1975) 1.02
Serum-free growth of adult human prostatic epithelial cells. In Vitro Cell Dev Biol (1986) 1.02
Observations on the growth of urethral and vaginal bacteria in sterile urine. J Urol (1980) 1.01
The natural history of symptomatic recurrent bacteriuria in women. Medicine (Baltimore) (1977) 1.00
Prediction of prostate cancer volume using prostate-specific antigen levels, transrectal ultrasound, and systematic sextant biopsies. Urology (1995) 1.00
Ultrasensitive assay of prostate-specific antigen used for early detection of prostate cancer relapse and estimation of tumor-doubling time after radical prostatectomy. Clin Chem (1995) 0.99
Evaluation of and antimicrobial therapy for recurrent urinary tract infections in women. Urol Clin North Am (1998) 0.99
Antibacterial concentrations in prostatic fluid. 1. Nitrofurantoin. J Urol (1967) 0.98
Renal cell carcinoma involving penis and testis: unusual initial presentations of metastatic disease. Urology (1991) 0.98
Stage A versus stage B adenocarcinoma of the prostate: morphological comparison and biological significance. J Urol (1988) 0.98
Pathological characteristics and prognosis of nonpalpable and palpable prostate cancers with a Hybritech prostate specific antigen of 4 to 10 ng./ml. J Urol (1996) 0.97
Adapted method for determination of inulin in serum and urine with an AutoAnalyzer. J Lab Clin Med (1968) 0.97
The passage of tetracyclines across epithelial membranes with special reference to prostatic epithelium. J Urol (1971) 0.97
Histological characteristics of radical prostatectomy specimens in men with a serum prostate specific antigen of 4 ng./ml or less. J Urol (1996) 0.96
Clonal growth of human prostatic epithelial cells is stimulated by fibroblasts. Prostate (1989) 0.95
Capsular penetration in prostate cancer. Significance for natural history and treatment. Am J Surg Pathol (1990) 0.94
Roles of glycoproteins and oligosaccharides found in human vaginal fluid in bacterial adherence. Infect Immun (1999) 0.94